A brutal selloff in tech stocks, fueled by fears that AI will disrupt traditional software revenues, contrasts with record highs for the equal-weight S&P 500, as retail traders step in to buy the dip.
The regional chain launches a dedicated program for professional drivers, rewarding fuel purchases with points redeemable for showers, drinks, and discounts—a strategic move to capture a loyal customer base in a competitive market.
After negotiations collapsed last year, the European Union and Australia are closing in on a landmark trade agreement, driven by geopolitical realignments and a shared aim to reduce economic dependencies.
While Calix's recent earnings report left some investors underwhelmed, a deeper look at its cash generation reveals a more robust financial foundation. The company's significant free cash flow, which far exceeded its reported profit, points to underlying strength that may not be fully reflected in the headline numbers.
Analysts at Piper Sandler and Citi have lifted price targets for Boot Barn Holdings, citing robust earnings growth, margin expansion drivers, and the mainstreaming of the western and workwear lifestyle segment.
JPMorgan has raised its earnings outlook for Lululemon Athletica following discussions with company executives at the ICR Conference, signaling confidence in the athletic apparel retailer's near-term trajectory amid a mixed analyst landscape.
The Swiss private banking group appoints Hamza Hamza to head its investment advisory division in Dubai, leveraging his two decades of regional experience to expand services for high-net-worth clients in the Gulf.
Healthcare distribution giant Cardinal Health (NYSE:CAH) reported robust fourth-quarter results for CY2025, with revenue soaring 18.8% year-over-year to $65.63 billion and adjusted EPS of $2.63 beating analyst forecasts, as CEO Jason Hollar highlights strength across all operating units.
Morgan Stanley and Citi have revised price targets for Dell Technologies, reflecting a CIO survey that points to the slowest hardware budget expansion in 15 years, despite resilient data center investment.
Williams Trading has downgraded On Holding (NYSE: ONON) from Buy to Hold, slashing its price target to $47 from $55. The firm warns that recent product segmentation moves may be counterproductive, potentially hurting wholesale growth and margins.
Stifel raises price target on Comfort Systems USA (FIX) to $1,196, maintaining a Buy rating. The firm anticipates the mechanical and electrical contractor could outperform in Q4 2025, buoyed by strong recent earnings, a massive backlog, and strategic acquisitions.
Wells Fargo and BMO Capital have raised their price targets on Take-Two Interactive following better-than-expected Q3 2025 bookings, with analysts highlighting strong execution and downplaying near-term AI-related concerns for the Grand Theft Auto publisher.
Amidst a global nuclear energy revival, uranium producer Cameco (CCJ) sees a bullish price target hike from Bernstein. While landmark deals signal long-term promise, operational delays and market hesitancy present near-term challenges for investors betting on a doubling stock.
The Hershey Company (NYSE: HSY) delivered a robust fourth-quarter performance for 2025, surpassing revenue and profit forecasts. However, underlying sales volume contraction raises questions about the chocolate giant's long-term growth strategy in a shifting consumer landscape.
HSBC raised its rating on Palantir Technologies after strong Q4 results, highlighting surging U.S. commercial demand for its AI platforms. The upgrade comes alongside a more cautious view from another firm, underscoring the debate over the data analytics company's premium valuation.
Citi analysts have upgraded Spotify Technology (NYSE: SPOT) from 'Neutral' to 'Buy', maintaining a $650 price target. The move highlights growing Wall Street confidence in the streaming giant's ability to boost profitability through strategic price hikes and an accelerated share repurchase program, even as subscriber growth in mature markets slows.
Citizens JMP maintains an Outperform rating on CRISPR Therapeutics (CRSP), arguing its drug pipeline is significantly undervalued and forecasting a pivotal late-stage development phase by 2027, even as it slightly lowers its price target.
The world's leading cryptocurrency has fallen below the $70,000 threshold for the first time since November 2024, as regulatory uncertainty and shifting market dynamics reverse the rally that followed Donald Trump's election victory.
The luxury fashion group behind Coach and Kate Spade posted a 14% revenue jump to $2.5 billion for the quarter, significantly exceeding analyst forecasts and sending its stock higher.
Shares of AtkinsRéalis Group (TSE:ATRL) have delivered a staggering 307% return over the past five years, significantly exceeding its earnings growth rate. The recent momentum suggests renewed investor confidence in the engineering giant's long-term strategy.
